Press-release for stocks related to drug for snynf

tags : Drug symbols : Snynf

save search

Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development
Published: 2024-04-15 (Crawled : 05:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -0.22% | O: -0.53% H: 0.61% C: 0.61%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -1.01% | O: 1.95% H: 0.0% C: 0.0%
drug als biomarker

AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -3.96% | O: -0.13% H: 0.0% C: -2.94%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -3.82% | O: -1.65% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -4.53% | O: -1.06% H: 0.21% C: -1.05%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.0% | O: -3.02% H: 0.0% C: 0.0%
drug label astrazeneca expansion for kids

Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published: 2024-04-10 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K

Health Technology

| -9.62% | O: -3.85% H: 1.2% C: 0.8%
iph45 pharma drug candidate antibody preclinical

FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -4.09% | O: -0.29% H: 1.34% C: -0.64%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.1% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -5.02% | O: 0.11% H: 0.37% C: -0.77%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.59% | O: 0.69% H: 0.0% C: 0.0%
fda drug schizophrenia

FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -2.29% | O: 0.14% H: 0.24% C: 0.24%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -4.03% | O: 0.0% H: 1.6% C: 0.89%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -6.83% | O: -0.03% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -5.53% | O: -0.56% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.83% | O: 0.3% H: 0.0% C: 0.0%
fda drug iclusig hypertension

Global Immune Thrombocytopenia Drug Markets, 2019-2022 and 2023-2029: Advanced Drug Delivery Technologies Transform Management, Second-Generation TPO-RAs Revolutionize Treatment Options
Published: 2024-03-12 (Crawled : 00:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.85% | O: -0.04% H: 0.0% C: 0.0%
drug treatment global advanced

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -0.69% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.8% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -11.91% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.31% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published: 2024-03-11 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -0.69% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.8% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -11.91% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.31% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.01% | O: 0.0% H: 0.8% C: 0.8%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.29% | O: -0.45% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K

Health Technology

| -8.56% | O: 0.78% H: 1.93% C: 0.97%
iph45 pharma drug antibody preclinical

AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published: 2024-03-05 (Crawled : 08:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.17% | O: 1.17% H: 0.0% C: 0.0%
lung drug cancer treatment application therapeutics

Rare Disease Drug Development Urgently Needs More Funding, Experts Say
Published: 2024-02-29 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -3.89% | O: -1.6% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.28% | O: -0.11% H: 0.0% C: 0.0%
rare drug disease

Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published: 2024-02-15 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K

Health Technology

| -53.57% | O: 0.79% H: 0.0% C: -3.21%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.42% | O: 1.66% H: 0.0% C: -1.59%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -5.89% | O: 1.66% H: 0.0% C: -1.04%
TRUMY | $16.507 0.79% 34K

Manufacturing

| -55.13% | O: 0.27% H: 0.0% C: -2.6%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -6.57% | O: 0.37% H: 0.57% C: 0.19%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.21% | O: -0.83% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| -6.47% | O: 0.01% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -2.15% | O: -0.6% H: 0.0% C: 0.0%
drug patent report review global advanced market

COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
Published: 2024-02-09 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -7.69% | O: -0.68% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -1.26% | O: 1.11% H: 0.0% C: 0.0%
covid-19 sales drug

Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
Published: 2024-02-07 (Crawled : 09:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 6.49% | O: 0.76% H: 4.31% C: 2.11%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -2.19% | O: 1.33% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M

Health Technology

| -11.42% | O: -0.65% H: 0.57% C: -3.21%
first management drug application china

National Tay-Sachs & Allied Diseases Association Hosts First of Its Kind Drug Development Meeting for GM2
Published: 2024-02-01 (Crawled : 14:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -8.22% | O: -4.37% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -11.03% | O: -5.26% H: 0.0% C: 0.0%
first drug association meeting

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

Health Technology

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $138.24 -4.19% 800

Health Technology

| 3.09% | O: 3.41% H: 0.0% C: -2.45%
VTRS A | $11.25 1.17% 1.16% 4.7M

Health Technology

| -5.84% | O: -0.08% H: 3.47% C: -0.25%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -13.61% | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| 1.3% | O: 4.04% H: 1.57% C: -3.02%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 0.15% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -9.47% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $5.01 0.4% 0.4% 290K

Health Technology

| 8.5% | O: -0.1% H: 2.31% C: -1.26%
AZN | News | $68.56 0.29% 0.29% 4.7M

Health Technology

| 1.58% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| -15.79% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

FDA Decisions: Theratechnologies Must Address Several Questions in CRL for Lipodystrophy Drug
Published: 2024-01-25 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -9.0% | O: 0.73% H: 0.3% C: -0.39%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.2% | O: -0.35% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -4.05% | O: 0.47% H: 1.04% C: 0.93%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -9.95% | O: -1.27% H: 0.0% C: 0.0%
fda drug lipodystrophy

Over-The-Counter Drug Market to Grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB as Key Market Contributors - 17000+ Technavio Reports
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
RBGPF | $51.61 6.46% 4.7K

Consumer Non-Durables

| -27.01% | O: -1.75% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -10.09% | O: -3.01% H: 0.69% C: -0.75%
AZNCF | News | $138.24 -4.19% 800

Health Technology

| 0.3% | O: -0.42% H: 0.0% C: -1.8%
RBGLY | $10.35 -2.05% 990K

Manufacturing

| -27.38% | O: -0.35% H: 0.07% C: -0.14%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -13.6% | O: 0.22% H: 0.43% C: -0.39%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| 0.81% | O: 0.48% H: 0.66% C: -1.11%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -7.36% | O: -3.45% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -9.13% | O: 0.92% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

Health Technology

| 2.27% | O: -0.03% H: 0.29% C: -0.19%
drug astrazeneca key therapeutics market

Sanofi Buys Inhibrx for Up to $2.2B to Bolster Inflammation Drug Pipeline
Published: 2024-01-23 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology